IgA-epidermolysis bullosa acquisita in a child resulting in blindness

British Journal of Dermatology

Volumn 137, Issue 2, 1997, Pages 270-275

  Caux, F ^a   Kirtschig, G ^b   Lemarchand Venencie, F ^a   Venencie, P Y ^c   Hoang Xuan, T ^d   Robin, H ^d   Dubertret, L ^a   Prost, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c BICÊTRE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; COMPLEMENT COMPONENT C3; DAPSONE; IMMUNOGLOBULIN A;

ARTICLE; BASEMENT MEMBRANE; BLINDNESS; BLISTER; CASE REPORT; CHEEK MUCOSA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPIDERMOLYSIS BULLOSA ACQUISITA; EYE DISEASE; FEMALE; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; INFANT; MOUTH LESION; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; SKIN; URTICARIA;

EID: 0030844768     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1997.18191915.x     Document Type: Article

References (31)

1. Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clinics 1993; 11: 535-47.
2. Lapiere JC, Woodley DT, Parente MG et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993; 92: 1831-9.
3. Prost C, Dubertret L, Fosse M et al. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol 1982; 101: 1-7.
4. McGrath JA, Ishida-Yamamoto A, O'Grady A et al. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol 1993; 100: 366-72.
5. van't Veen AJ, Heule F, Vuzevski VD, Den Hengst CW. Epidermolysis bullosa acquisita. Br J Dermatol 1994; 131: 724-5.
6. Raab B, Fretzin DF, Bronson DM et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. JAMA 1983; 250: 1746-8.
7. Balding SD, Prost C, Diaz LA et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996; 106: 141-6.
8. Domloge-Hultsch N, Anhalt G, Gammon WR et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 1994; 130: 1521-9.
9. Woodley DT. Immunofluorescence on salt-split skin for the diagnosis of epidermolysis bullosa acquisita. Arch Dermatol 1990; 126: 229-301.
10. Rusenko KW, Gammon WR, Briggaman RA. Type VII collagen is the antigen recognized by IgA anti-sublamina densa autoantibodies. J Invest Dermatol 1989; 92: 510A.
11. Hashimoto T, Ishiko A, Shimizu H et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Er J Dermatol 1996; 134: 336-9.
12. Zambruno G, Manca V, Kanitakis J et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 1994; 31: 884-8.
13. Lacour JP, Bernard P, Rostain G et al. Childhood acquired epidermolysis bullosa. Pediatr Dermatol 1995; 12: 16-20.
14. Inauen P, Hunziker TH, Gerber H et al. Childhood epidermolysis bullosa acquisita. Br J Dermatol 1994; 131: 898-900.
15. Roger H, Machado P, Nicolas JF et al. Epidermolysis bullosa acquisita in a 31/2-year-old girl. J Am Acad Dermatol 1992; 27: 858-62.
16. Arpey CJ, Elewski BE, Moritz DK, Gammon WR. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol 1991; 24: 706-14.
17. Espagne E, Prost C, Janssen F et al. Epidermolyse bulleuse acquise de l'enfant. A propos d'un cas. Ann Dermatol Venereol 1990; 117: 814-16.
18. Kirtschig G, Wojnarowska F, Marsden RA et al. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting. Br J Dermatol 1994; 130: 610-16.
19. Lang PG, Tapert MJ. Severe ocular involvement in a patient with epidermolysis bullosa acquisita. J Am Acad Dermatol 1987; 16: 439-43.
20. Stewart MI, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol 1991; 127: 373-7.
21. Aclimandos WA. Corneal perforation as a complication of epidermolysis bullosa acquisita. Eye 1995; 9: 633-6.
22. Zierhut M, Thiel H-J, Weidle EG et al. Ocular involvement in epidermolysis bullosa acquisita. Arch Ophthalmol 1989; 107: 398-401.
23. Richter BJ, McNutt NS. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979; 115: 1325-8.
24. Iwamoto M, Haik BG, Iwamoto T et al. The ultrastructural defect in conjunctiva from a case of recessive dystrophic epidermolysis bullosa. Arch Ophthalmol 1991; 109: 1382-6.
25. Merle C, Blanc D, Zultak M et al. Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A. Dermatologica 1990; 181: 44-7.
26. Crow LL, Finkle JP, Gammon WR, Woodley DT. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1988; 19: 937-42.
27. Gupta AK, Ellis CN, Nickoloff BJ et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. Arch Dermatol 1990; 126: 339-50.
28. Cunningham BB, Kirchmann TTT, Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996; 34: 781-4.
29. Miller JL, Stricklin GP, Fine JD et al. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995; 133: 467-71.
30. Mohr C, Sunderkötter C, Hildebrand A et al. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol 1995; 132: 824-6.
31. Meier F, Sönnichsen K, Schaumburg-Lever G et al. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1993; 29: 334-7.